|
US7615368B1
(en)
|
1994-06-17 |
2009-11-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarrays of polypeptides
|
|
WO2000063701A2
(en)
*
|
1999-04-15 |
2000-10-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarrays of polypeptides
|
|
EP1158058A1
(en)
*
|
2000-05-19 |
2001-11-28 |
Centre National De La Recherche Scientifique |
Compositions and methods suitable for nucleic acid analyses
|
|
EP1377827A2
(en)
*
|
2001-04-10 |
2004-01-07 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen in Reutlingen Stiftung Bürgerlichen Rechts |
Method for determining analyte molecules in a sample
|
|
DK1502102T3
(en)
*
|
2002-03-11 |
2009-05-04 |
Caprotec Bioanalytics Gmbh |
Compounds and Methods for Analyzing the Proteome
|
|
ATE489629T1
(en)
|
2003-01-16 |
2010-12-15 |
Caprotec Bioanalytics Gmbh |
METHOD FOR IDENTIFYING NON-TARGETED PROTEINS
|
|
US20040248323A1
(en)
|
2003-06-09 |
2004-12-09 |
Protometrix, Inc. |
Methods for conducting assays for enzyme activity on protein microarrays
|
|
KR100690948B1
(en)
|
2004-06-17 |
2007-03-09 |
한국과학기술원 |
Microbial surface expression method of target protein using outer membrane protein of E. coli
|
|
KR100784261B1
(en)
|
2006-01-02 |
2007-12-11 |
한국과학기술원 |
Microbial surface expression method of target protein using spore envelope membrane protein of anthrax
|
|
ES2638779T3
(en)
|
2009-03-16 |
2017-10-24 |
Pangu Biopharma Limited |
Compositions and procedures comprising variants of histidyl tarn synthetase splicing that have non-canonical biological activities
|
|
US20100310576A1
(en)
|
2009-03-31 |
2010-12-09 |
Adams Ryan A |
COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
|
|
CA2797093C
(en)
|
2010-04-26 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
|
AU2011248614B2
(en)
|
2010-04-27 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
|
|
US8993723B2
(en)
|
2010-04-28 |
2015-03-31 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
|
|
WO2011135459A2
(en)
|
2010-04-29 |
2011-11-03 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy
|
|
EP2563912B1
(en)
|
2010-04-29 |
2018-09-05 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
|
EP2563383B1
(en)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
|
AU2011248355B2
(en)
|
2010-05-03 |
2017-01-19 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Arginyl-tRNA synthetases
|
|
AU2011248227B2
(en)
|
2010-05-03 |
2016-12-01 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
|
CA2797978C
(en)
|
2010-05-03 |
2019-12-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
|
CA2798139C
(en)
|
2010-05-04 |
2019-09-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
|
WO2011143482A2
(en)
|
2010-05-14 |
2011-11-17 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
WO2011146410A2
(en)
|
2010-05-17 |
2011-11-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
|
|
JP6046607B2
(en)
|
2010-05-27 |
2016-12-21 |
エータイアー ファーマ， インコーポレイテッド |
Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl tRNA synthetase
|
|
CN103118694B
(en)
|
2010-06-01 |
2016-08-03 |
Atyr医药公司 |
The discovery for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of lysyl-tRNA synzyme
|
|
CA2804416C
(en)
|
2010-07-12 |
2020-04-28 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
|
US9029506B2
(en)
|
2010-08-25 |
2015-05-12 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
|
|
CN103930563B
(en)
|
2011-06-01 |
2016-11-09 |
医学预后研究所 |
For the method and apparatus predicting cancer return
|
|
JP6170077B2
(en)
|
2012-02-16 |
2017-07-26 |
エータイアー ファーマ， インコーポレイテッド |
Histidyl tRNA synthetase for treating autoimmune and inflammatory diseases
|
|
MX367366B
(en)
|
2012-11-27 |
2019-08-16 |
Univ Pontificia Catolica Chile |
Compositions and methods for diagnosing thyroid tumors.
|
|
CN103245788B
(en)
*
|
2013-03-22 |
2015-01-21 |
赵树民 |
Peptide array synthesis technology for B cell antigen epitope screening
|
|
WO2014195032A1
(en)
|
2013-06-07 |
2014-12-11 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
|
|
EP3169815B1
(en)
|
2014-07-15 |
2020-12-23 |
Ontario Institute For Cancer Research |
Methods and devices for predicting anthracycline treatment efficacy
|
|
KR102670705B1
(en)
|
2015-01-02 |
2024-05-31 |
다케다 파머수티컬 컴패니 리미티드 |
Bispecific antibodies against plasma kallikrein and factor XII
|
|
CN108137705B
(en)
|
2015-07-21 |
2022-11-08 |
武田药品工业株式会社 |
Monoclonal antibody inhibitor of factor XIIA
|